Skip to content
City PM
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
Tuesday 13 February 2024 6:02 am  |  Updated:  Tuesday 13 February 2024 9:29 pm

One-third of women avoid a gynaecology visit due to embarrassment

By: Laura Forsyth

Add as a preferred source on Google
A survey found that 59 per cent of women in the UK have delayed a gynaecology visit; with a third avoiding going due to embarrassment.
A survey found that 59 per cent of women in the UK have delayed a gynaecology visit; with a third avoiding going due to embarrassment.

Research has found that 81 per cent of British women consider visiting a gynaecology for a cervical cancer screening a critical part of their health management.

However, over half find the guidance on cervical cancer screening confusing, and do not understand the difference between a pap test and an HPV test.

BD, a leading global medical technology company, shares the results of a Harris Poll survey, which highlights gaps in cervical cancer screening access.

It found that 59 per cent of women in the UK have delayed a gynaecology visit; with a third of British women avoiding a gynaecology visit due to embarrassment.

The survey also found that 46 per cent of women mistakenly believe that Pap (Papanicolaou) tests are the most accurate test for detecting cervical cancer.

Self-collection for cervical cancer screening is a viable option for increasing access and health equity. it is already available in countries around the world, including Denmark, Sweden, the Netherlands, Kenya, Australia, and New Zealand. it is not yet available in the UK.

The majority of women in the UK (63 per cent) say they would be comfortable doing a self-collected vaginal test at home to screen for cervical cancer.

Read more

Araris Biotech AG and Taiho Oncology Announce Dosing of First Patient in Phase 1 Trial of ARC-02, a Novel ADC for the Treatment of Non-Hodgkin Lymphoma

Most women in the UK (70 per cent) would be interested in at-home screening for HPV or cervical cancer, the survey also reported.

DrJeff Andrews, a gynaecologist and vice president of medical affairs for Integrated Diagnostic Solutions at BD shares his advice.

“A pap test looks for existing abnormalities, including cervical precancer or cancer. An HPV assay is more sensitive than Pap tests and can identify the potential for abnormalities to develop. When a woman has a positive HPV result, it is important to know what kind of HPV she has. There are different types or strains. The risk of progression varies by type and duration. The persistence of infection with the same type can be determined with an HPV assay that reports the types.

“As a physician, I must educate patients about ways to prevent and options to screen for cervical precancer. As patients, women deserve more information on how they are being tested, including the type of test, how often they are being tested and why. Screening techniques advance and guidelines change.

“My patients are interested in knowing more about HPV, the types, the risks, and the management of abnormal results. More knowledge about high-risk HPV types and cervical cancer screening can empower people with a cervix to take greater control of their health.”

What can you do to reduce the risk cervical cancer?

  1. See a gynaecologist every year
  2. Ask a doctor about HPV testing and get the HPV vaccine
  3. Use protection during sex as HPV is the most common STD today.
Read more

What’s On In July

Central London skyline showcasing iconic landmarks and July events, highlighting the citys vibrant cultural scene.

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • Life&Style

Categories

  • Wellness

Related Topics

  • Health

Trending Articles

  • Brewdog chief executive quits after only one year

  • Burnham tax plans spark investor rush to bank capital gains

  • Housebuilding giants hit with £4.5bn lawsuit for allegedly overcharging buyers

  • UK ‘no longer a serious place’ says Hedge fund boss after losing £200m tax battle

  • Canary Wharf’s reinvention is a triumph

More from City PM

  • Araris Biotech AG and Taiho Oncology Announce Dosing of First Patient in Phase 1 Trial of ARC-02, a Novel ADC for the Treatment of Non-Hodgkin Lymphoma

    Business Wire
  • What’s On In July

    Partner
    Central London skyline showcasing iconic landmarks and July events, highlighting the citys vibrant cultural scene.
  • Kia Oval worth £80m to the UK economy as Test gets underway

    Sport Business
    Cityscape at dusk showcasing skyline with prominent skyscrapers under a vibrant sky, ideal for business news context.
  • GSK shares slip after buying US cancer treatment firm Nuvalent for $10.6bn

    Pharma
    GSK logo displayed prominently, signifying the companys presence and relevance in the business and healthcare sectors.
  • People named Mark called upon to raise money at London charity golf day

    Sport Business
    Breaking news concept with digital globe and newspaper headlines on a blue background, representing global journalism.
  • Carrying debt into retirement isn’t always bad news

    Opinion
    Woman and man discussing retirement savings, highlighting gender pension gap and financial planning differences
  • Anocca has Dosed First Patients with Precision TCR-T Cell Therapy Targeting Mutant KRAS in Pancreatic Cancer

    Business Wire
  • Mary Kay Extends Winning Streak With Fourth Year as #1 in Global Direct Selling Beauty

    Business Wire

City PM — European politics, business and analysis.

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Topics

  • Business
  • Markets
  • AI
  • Technology
  • Opinion
  • Energy

More

  • Politics
  • Economics
  • Fintech
  • Legal
  • Sport
  • Life

Company

  • About City PM
  • Editorial Policy
  • Corrections
  • Contact
  • Terms of Use
  • Privacy Policy
  • Cookie Policy
© 2026 City PM · Published by CityPM Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
About · Editorial Policy · Corrections · Contact · Privacy